ACME Laboratories (DHA:ACMELAB) Change In Payables And Accrued Expense : BDT0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is ACME Laboratories Change In Payables And Accrued Expense?

ACME Laboratories's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2024 was BDT0 Mil. It means ACME Laboratories's Accounts Payable & Accrued Expense stayed the same from Sep. 2024 to Dec. 2024 .

ACME Laboratories's Change In Payables And Accrued Expense for the fiscal year that ended in Jun. 2024 was BDT0 Mil. It means ACME Laboratories's Accounts Payable & Accrued Expense stayed the same from Jun. 2023 to Jun. 2024 .

ACME Laboratories Change In Payables And Accrued Expense Historical Data

The historical data trend for ACME Laboratories's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ACME Laboratories Change In Payables And Accrued Expense Chart

ACME Laboratories Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

ACME Laboratories Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

ACME Laboratories Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT0 Mil.

ACME Laboratories Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of ACME Laboratories's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

ACME Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ACME Laboratories Ltd (DHA:ACMELAB) » Definitions » Change In Payables And Accrued Expense

Traded in Other Exchanges

N/A

Address

1/4, Kallayanpur, Mirpur Road, Court de la ACME, Dhaka, BGD, 1207

Website

https://www.acmeglobal.com

ACME Laboratories Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products in Bangladesh. The Company is engaged in manufacturing, marketing, and distribution of generic pharmaceuticals formulation products which includes human drugs comprising dosages form like a tablet, capsule, dry syrup, cream, ointment, powder, injection, dry powder inhaler, metered dosage inhaler, suppository, eye and nasal drop, liquid, liquid in hard gelatine, Blow Fill Seal (BFS) products, sachet products; veterinary drugs comprising dosages form like bolus, liquid,injection, water-soluble powder, premix and herbal drugs comprising dosages form like liquid, capsule, tablet, cream. The products of the company are sold in domestic and international markets.

ACME Laboratories Headlines

No Headlines